問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Kaoshiung Chang Gung Memorial Hospital of the C.G.M.F.
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2016-03-01 - 2023-03-01
Condition/Disease
Previously Untreated Activated B-cell Type Diffuse Large B-cell Lymphoma
Test Drug
Lenalidomide (CC-5013)
Participate Sites6Sites
Terminated5Sites
2016-02-01 - 2019-05-01
Hepatocellular Carcinoma
Nivolumab/Sorafenib
Participate Sites8Sites
Terminated7Sites
Division of Hematology & Oncology
未分科
2016-07-01 - 2020-06-30
NON-SMALL CELL LUNG CANCER (NSCLC)
Atezolizumab (MPDL3280A)
Participate Sites10Sites
Terminated9Sites
2016-07-05 - 2020-07-05
Advanced or Recurrent Gastric Cancer
Nivolumab
Participate Sites12Sites
Terminated10Sites
2014-08-01 - 2024-06-20
Multiple Myeloma Following Autologous Stem Cell Transplant
Ixazomib Citrate (MLN9708)
Participate Sites5Sites
2015-02-01 - 2016-12-31
Participate Sites3Sites
Terminated3Sites
2010-09-30 - 2013-10-31
Terminated8Sites
2010-12-01 - 2012-12-31
2010-09-30 - 2014-08-31
Participate Sites9Sites
2010-10-01 - 2016-09-30
全部
